Li et al. showed that LINC00680 inhibits the growth of BC cells by affecting the miR-320b/CDKL5 axis of cell proliferation and invasion, promoting doxorubicin resistance in BC cells (Li et al., 2022). The gene discussed is CDKL5; the disease is breast cancer.